# New applications of sustainable, scalable, standardized, and cost-effective human biomaterials for cell-based assays, tissue engineering, and regenerative medicine

**Authors:** Rebekka J. S. Salzmann, Sandra Domazet, Sonia Prado-López, Seyda Kigili, Winfried Neuhaus, Andreas Brachner, Gerda Egger, Lorenzo Moroni, Johannes Hackethal

PMC · DOI: 10.3389/fbioe.2025.1676369 · Frontiers in Bioengineering and Biotechnology · 2026-01-02

## TL;DR

Human placenta-derived biomaterials offer a sustainable and ethical alternative to animal-derived materials for cell culture and tissue engineering.

## Contribution

The study introduces new applications of placenta-derived materials for 2D and 3D cell culture systems.

## Key findings

- Collagen type-I coatings supported colorectal cancer spheroid formation without growth-factor supplementation.
- Laminin-111 enhanced NIH3T3 fibroblast adhesion better than poly-L-lysine and rat-tail collagen.
- HUMAN PLACENTA substrate enabled endothelial monolayers with resistance comparable to conventional coatings.

## Abstract

Human-derived biomaterials offer several advantages over animal-derived or synthetic alternatives, including improved biocompatibility, ethical acceptability, sustainability, and clinical translatability. Here we present new applications of human placenta-derived materials – specifically HUMAN PLACENTA substrate, collagen type-I, and Laminin-111 – as 2D coating materials and 3D matrices for the cultivation of spheroids and adherent cells. Collagen type-I coatings supported colorectal cancer spheroid formation without the need for growth-factor supplementation. Lm-111 significantly enhanced NIH3T3 fibroblast adhesion compared with poly-L-lysine and rat-tail collagen type-I, performing comparably to bovine fibronectin. In a transwell blood–brain barrier model, HUMAN PLACENTA substrate coatings enabled confluent endothelial monolayers with transendothelial electrical resistance values not significantly different from the conventional human collagen type-IV/bovine fibronectin mixture. Across these in vitro models, placenta-derived materials performed comparably or better than conventional animal-derived and synthetic coatings, supporting robust cell viability, adhesion, and barrier formation. Due to their human origin, these biomaterials exhibit reduced biological complexity while enhancing biocompatibility and translational relevance. Therefore, they provide a sustainable, ethically acceptable alternative for advanced cell culture systems.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}
- **Diseases:** colorectal cancer (MESH:D015179)
- **Chemicals:** HUMAN PLACENTA (-)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Stachytarpheta cayennensis (blue snakeweed, species) [taxon 39376], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12808481/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12808481/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12808481/full.md

---
Source: https://tomesphere.com/paper/PMC12808481